Skip to content

Clinical trials

Phase 3 Oppositional Defiant Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Oppositional Defiant Disorder Phase: Phase 3 Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20061
20101
20111
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Janssen Pharmaceutica N.V., Belgium2
IWK Health Centre1
Ohio State University1
Pharmasoft1
Tufts Medical Center1
University of Cologne1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Oppositional Defiant Disorder9
Attention Deficit Disorder with Hyperactivity7
Attention Deficit and Disruptive Behavior Disorders3
Conduct Disorder3
Adjustment Disorders1
Anxiety Disorders1
Bipolar Disorder1
Child Development Disorders, Pervasive1
Disruptive, Impulse Control, and Conduct Disorders1
Mental Disorders1

Trials

Showing 51 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.